Home » Ask & Discuss » Biology (for Medical Entrance) » Botany « Back to Discussion
Botany
Comments (16)

Three radioactive blood flow markers (RBFMs) are clinically available and in widespread use:
(1) thallium Tl 201 chloride,
(2) technetium Tc-99m sestamibi (Cardiolite; Lantheus Medical Imaging, North Billerica, Mass), and
(3) technetium Tc-99m tetrofosmin (Myoview; GE Healthcare, Princeton, NJ). In the present review,
These agents will be referred to by their nonproprietary names. The oldest of the 3 RBFMs, thallium 201, has been in use since approximately 1980, and the original experimental and clinical validation studies of MPI were performed with this agent. More recently, 99mTc-labeled sestamibi, approved in 1990, and tetrofosmin, approved in 1995, have been developed and validated clinically.











